Biopharmaceutical, COVID-19, Manufacturing

Perhaps the biggest achievement thus far at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has been disabusing companies that are members of the Manufacturing USA innovation institute that it is smart to be “a fast second” to market.

“Nobody actually believed when we started, except apparently us naively, that we...

Delaware Business Times

In December 2016, Manufacturing USA, a newly developed unit within the Commerce Department’s National Institute for Standards and Technology (NIST), announced it had received Congressional funding for its newest and 11th institute – the National Institute for Innovation in Manufacturing Biopharmaceuticals, or NIIMBL for short. With the formal NIST...

Genetic Engineering & Biotechnology News
Biopharmaceutical, COVID-19, Innovation

In February 2020, NIIMBL ran a three-day workshop, which included participants from the FDA, the U.S. National Institute of Standards and Technology, plus what Erickson describes as “distinguished leaders in manufacturing and process development from 14 major manufacturers and suppliers.”

In January 2021, a team of pharmaceutical experts published...

Biomanufacturing, COVID-19, Workforce

Lifesaving vaccines and medicines. Working with a team. The ability to grow and develop. You'll find all of this and more in the biopharma manufacturing industry.

While many people think biopharma jobs are for those with science degrees, there are opportunities for workers with educational backgrounds of all types. People from all walks of life and...